Topical Absorbable Hemostat

Topical Absorbable Hemostat Market Outlook

The global topical absorbable hemostat market is projected to reach approximately USD 1.8 billion by 2035, growing at a compound annual growth rate (CAGR) of around 5% from 2025 to 2035. This growth is driven by increasing surgical procedures globally, where effective hemostatic solutions are essential for minimizing blood loss and promoting rapid healing. Additionally, advancements in medical technologies and the growing demand for minimally invasive surgeries are expected to further propel the market. The rising prevalence of chronic diseases requiring surgical interventions, along with an aging population, adds to the demand for effective hemostatic products. Moreover, the trend towards enhanced patient safety and quicker recovery times continues to influence the adoption of topical absorbable hemostats in various medical fields.

Growth Factor of the Market

Several key factors are contributing to the growth of the topical absorbable hemostat market. Firstly, the increasing incidence of trauma cases and surgical procedures has led to a heightened need for effective hemostatic agents, which are vital in controlling bleeding during operations. This demand is further fueled by the ongoing advancements in surgical techniques and the growing trend towards minimally invasive surgeries, which require precise and effective hemostatic solutions. Additionally, the emphasis on patient safety and quality healthcare has pushed hospitals and surgical centers to adopt innovative hemostatic products that ensure quicker healing and reduced complications. Furthermore, the expansion of healthcare facilities and the rising number of surgical professionals contribute to the market growth by enhancing the accessibility of these products. Lastly, the growing investment in healthcare infrastructure, especially in developing countries, is anticipated to bolster the demand for topical absorbable hemostats across various surgical applications.

Key Highlights of the Market

• Projected market size of approximately USD 1.8 billion by 2035.
• CAGR of around 5% from 2025 to 2035.
• Increased demand driven by rising surgical procedures globally.
• Growing emphasis on patient safety and quick recovery times.
• Technological advancements in hemostatic product formulations.

By Product Type

Collagen-based Hemostats:

Collagen-based hemostats are derived from natural collagen, which plays a crucial role in the wound healing process. These products are highly effective in promoting hemostasis as they facilitate the aggregation of platelets and enhance the body's natural healing mechanisms. Their biocompatibility and biodegradability make them favorable in various surgical applications. They are particularly beneficial in procedures involving soft tissues, as they promote rapid tissue regeneration while being absorbed by the body. The increasing utilization of collagen-based hemostats in surgeries such as orthopedic and cardiovascular procedures significantly contributes to their growing market share. The rising awareness of the advantages of using biocompatible materials in surgical settings further supports this demand, making collagen-based options a preferred choice among surgeons.

Gelatin-based Hemostats:

Gelatin-based hemostats are derived from porcine or bovine sources and are known for their rapid absorption and effective hemostatic properties. These hemostatic agents work by providing a scaffold for platelet aggregation and enhancing clot formation in the body. They are particularly useful in surgeries that involve significant blood loss, as they can control hemorrhage quickly. Their ease of use, combined with efficient hemostatic action, has led to their widespread adoption in various surgical specialties, including general and orthopedic surgeries. Moreover, the gelatin-based hemostats can be easily applied in both dry and wet forms, making them versatile for different surgical needs. As surgeons increasingly recognize their benefits, the demand for gelatin-based products is expected to rise significantly in the coming years.

Oxidized Regenerated Cellulose-based Hemostats:

Oxidized regenerated cellulose (ORC) hemostats are synthetic products that provide a matrix for blood clotting. These hemostats are effective in controlling mild to moderate bleeding and are often used in surgical procedures where traditional methods may be ineffective. The ORC products work by promoting the formation of a stable clot, which is enhanced by the presence of oxidized cellulose in the matrix. Their unique properties, such as biocompatibility and biodegradability, along with their ability to be easily manipulated into different forms, allow for their use in a variety of surgical settings. The increasing adoption of ORC hemostats in areas like neurosurgery and cardiovascular surgery, where precision and speed are paramount, drives their market growth.

Thrombin-based Hemostats:

Thrombin-based hemostats involve the use of thrombin, a key enzyme in the coagulation process, to promote hemostasis. These products are particularly effective in areas where rapid clot formation is required, making them invaluable in surgeries with high bleeding risk. Thrombin-based agents can be used alone or in combination with other hemostatic agents to enhance their efficacy. The ability of thrombin to activate platelets and enhance the natural clotting process makes these products essential in surgical procedures such as cardiovascular and orthopedic surgeries. The growing recognition of their effectiveness and the continuous development of novel formulations are expected to enhance their market presence significantly.

Combination Hemostats:

Combination hemostats utilize a blend of various components to achieve optimal hemostatic effects. By integrating the benefits of different hemostatic agents, these products aim to provide superior control of bleeding during surgical procedures. Combination hemostats can be tailored to meet specific surgical needs, making them highly versatile. Their application in a wide range of surgical specialties, from general surgery to complex orthopedic procedures, positions them as a crucial element in the surgical toolkit. As the demand for customized surgical solutions grows, the market for combination hemostats is anticipated to expand, offering healthcare providers innovative approaches to managing hemostasis.

By Application

Cardiovascular Surgery:

Cardiovascular surgery is one of the most critical applications for topical absorbable hemostats due to the high risk of bleeding associated with such procedures. Hemostatic agents play a vital role in controlling blood loss during operations like coronary artery bypass grafting and valve replacements. The use of effective hemostats allows surgeons to maintain a clear operative field and promotes quicker recovery by reducing the likelihood of complications such as hematoma formation. The increasing number of cardiovascular surgeries worldwide, driven by the rising prevalence of heart diseases, significantly contributes to the demand for these hemostatic products in this segment. As innovations in surgical techniques continue to evolve, the reliance on advanced hemostatic solutions will further bolster the market for cardiovascular applications.

General Surgery:

General surgery encompasses a wide range of surgical procedures, making it a significant application area for topical absorbable hemostats. These products are utilized to manage bleeding in various surgeries, including appendectomies, cholecystectomies, and hernia repairs. The effectiveness of hemostatic agents in controlling bleeding not only improves the surgical outcomes but also enhances recovery times for patients. With a growing emphasis on minimally invasive techniques, surgeons increasingly rely on topical absorbable hemostats to ensure patient safety and reduce blood loss during operations. The expanding number of general surgical procedures performed globally is expected to drive the demand for hemostatic products, facilitating their market growth.

Orthopedic Surgery:

Orthopedic surgery is another critical area where topical absorbable hemostats are extensively used, particularly in procedures involving significant trauma or bone fractures. These hemostatic agents are crucial in controlling bleeding during complex surgeries such as joint replacements and spinal fusions. The ability to manage bleeding effectively not only enhances surgical efficiency but also minimizes the risk of complications post-surgery. The rising incidence of orthopedic surgeries, attributed to factors such as an aging population and increased participation in sports, underscores the growing demand for effective hemostatic solutions. As orthopedic surgeons continue to seek innovative products that enhance patient outcomes, the market for topical absorbable hemostats in this application is likely to expand.

Neurosurgery:

In the domain of neurosurgery, where precision and control over bleeding are paramount, topical absorbable hemostats play an essential role. These products are utilized in various surgical procedures involving the brain and spinal cord, where effective hemostasis is critical to achieving optimal outcomes. Hemostatic agents not only help maintain a clear surgical field but also reduce the risks associated with excessive bleeding, which can lead to severe complications. The increasing complexity of neurosurgical procedures and the rising number of patients requiring such surgeries further drive the demand for innovative hemostatic solutions in this field. As advancements in neurosurgery continue to emerge, the reliance on effective hemostatic products is expected to grow significantly.

Others:

Beyond the major applications, topical absorbable hemostats are also utilized in various other surgical specialties, including urology, gynecology, and trauma surgery. These products are essential for controlling bleeding in less common but equally critical procedures. The versatility of hemostatic agents makes them applicable in diverse surgical settings, enhancing their overall market potential. As healthcare providers across various specialties recognize the importance of effective hemostasis in improving patient outcomes and reducing complications, the demand for topical absorbable hemostats is anticipated to grow steadily across these additional applications.

By Distribution Channel

Hospitals:

Hospitals represent one of the primary distribution channels for topical absorbable hemostats due to their extensive surgical departments and high patient turnover. The demand for effective hemostatic solutions in hospitals is driven by the constant need to manage bleeding during various surgical procedures, ensuring optimal patient care and outcomes. With hospitals increasingly investing in advanced medical technologies and prioritizing patient safety, the adoption of topical absorbable hemostats has become a standard practice. The growing number of surgical procedures performed in hospitals, along with the emphasis on minimizing complications, further solidifies this distribution channel's significance in the overall market.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) have emerged as a vital distribution channel for topical absorbable hemostats, offering a wide range of surgical services. ASCs are known for their efficiency in providing outpatient surgical procedures, which often require effective hemostatic solutions to ensure patient safety and rapid recovery. The growing trend towards outpatient surgeries, fueled by advancements in surgical techniques and a focus on reducing hospital stays, has led to an increased demand for hemostatic products in these facilities. As ASCs continue to expand and cater to a broader patient base, the market for topical absorbable hemostats in this channel is likely to experience significant growth.

Specialty Clinics:

Specialty clinics cater to specific medical fields, such as dermatology, urology, and orthopedics, making them a prominent distribution channel for topical absorbable hemostats. These clinics often perform minor surgical procedures where effective hemostasis is essential to prevent complications. The increasing number of specialty clinics and the growing trend of patients seeking specialized care contribute to the demand for hemostatic agents in these settings. As healthcare practices continue to evolve, the role of specialty clinics in the distribution of topical absorbable hemostats is expected to strengthen, driven by the need for tailored surgical solutions.

Online Sales:

The rise of e-commerce has transformed the distribution landscape for topical absorbable hemostats, with online sales becoming an increasingly popular channel. Healthcare providers and clinics appreciate the convenience of sourcing products online, where they can access a broader range of hemostatic options and compare prices easily. The growing trend of digitalization in the healthcare sector, coupled with the expansion of online pharmacies and medical supply platforms, has further propelled the demand for online sales. This channel offers flexibility and ease of access, ensuring that healthcare providers can quickly obtain the necessary hemostatic products to enhance patient care. As online purchasing continues to gain traction, it is likely to play a significant role in the overall market for topical absorbable hemostats.

By Ingredient Type

Plant-based:

Plant-based hemostatic agents are derived from natural sources such as plant extracts and are gaining popularity due to their biocompatibility and safety. These products are appreciated for their eco-friendly nature and reduced risk of adverse reactions compared to synthetic alternatives. Plant-based hemostats can effectively promote clotting and tissue healing, making them suitable for a variety of surgical applications. The increasing awareness of sustainability and the growing demand for natural products in healthcare are driving the adoption of plant-based hemostatic solutions. As research continues to unveil the potential benefits of these products, their role in the market is expected to expand significantly.

Animal-based:

Animal-based hemostats, derived from sources such as bovine or porcine tissues, are commonly used in various surgical procedures due to their effectiveness in promoting hemostasis. These products leverage the natural properties of animal-derived materials to facilitate blood clotting and enhance wound healing. While they are widely recognized for their effectiveness, there is also a growing concern regarding the risk of allergic reactions and disease transmission associated with animal-based products. Despite these concerns, the increasing number of surgical procedures and the demand for effective hemostatic solutions ensure that animal-based hemostats continue to maintain a significant share of the market.

Synthetic:

Synthetic hemostatic agents are engineered products designed to mimic the properties of natural hemostatic solutions. These products offer a high degree of customization, allowing for tailored solutions that meet specific surgical needs. Synthetic hemostats are often preferred for their consistency in performance and their ability to be produced in a controlled environment, minimizing the risk of contamination. The continuous advancements in synthetic materials and technologies have resulted in innovative hemostatic solutions that enhance surgical outcomes. As the demand for reliable and effective hemostatic products grows, the market for synthetic hemostats is expected to expand rapidly.

By Region

North America holds a significant share of the topical absorbable hemostat market, driven by advanced healthcare infrastructure and the high volume of surgical procedures performed annually. The region's emphasis on patient safety and quality care has led to the widespread adoption of innovative hemostatic solutions in hospitals and surgical centers. Furthermore, the presence of key market players and ongoing research and development initiatives contribute to the growth of the market in North America. The CAGR for this region is expected to be around 4.5% between 2025 and 2035, highlighting its robust growth potential. The increasing prevalence of chronic diseases and the rise in trauma cases further augment the demand for effective hemostatic products in this region.

In Europe, the topical absorbable hemostat market is also witnessing substantial growth, owing to a rising number of surgical procedures and a growing focus on minimizing surgical complications. The region's healthcare systems prioritize innovative medical solutions, leading to the increased adoption of advanced hemostatic agents. Countries like Germany, France, and the UK play a significant role in boosting market growth due to their well-established healthcare infrastructure and high demand for surgical interventions. The market in Europe is projected to grow at a CAGR of approximately 4% from 2025 to 2035. As the aging population continues to increase and the demand for safe surgical solutions rises, Europe is anticipated to remain a key player in the topical absorbable hemostat market.

Opportunities

The topical absorbable hemostat market presents numerous opportunities for growth in the coming years. One significant opportunity lies in the increasing prevalence of chronic diseases requiring surgical interventions, such as diabetes, cardiovascular diseases, and obesity-related complications. As these conditions necessitate a higher volume of surgical procedures, the demand for effective hemostatic solutions will rise correspondingly. Additionally, the advancement of surgical technologies, particularly in minimally invasive techniques, creates a favorable environment for the adoption of innovative hemostatic products that offer better patient outcomes and shorter recovery times. Furthermore, the growing awareness of patient safety and the need for improved surgical practices will drive healthcare providers to seek out advanced hemostatic solutions, providing a robust opportunity for market players.

Another promising opportunity exists in emerging markets, where rapid economic growth and ongoing healthcare infrastructure development are creating new avenues for the expansion of the topical absorbable hemostat market. Countries in Asia Pacific, Latin America, and the Middle East & Africa are increasingly investing in healthcare facilities and surgical capabilities, leading to a higher demand for effective hemostatic products. As these regions continue to develop, the market for topical absorbable hemostats is expected to witness significant growth. Moreover, partnerships and collaborations between manufacturers and healthcare providers can further enhance the availability and distribution of these products, providing additional opportunities for market expansion.

Threats

Despite the positive growth outlook for the topical absorbable hemostat market, certain threats could hinder its progress. One significant threat is the increasing competition from alternative hemostatic solutions, such as mechanical devices and advanced suturing techniques. As new technologies emerge, they may offer effective bleeding control mechanisms that compete with traditional hemostatic products. Additionally, the growing trend towards personalized medicine and tailored surgical solutions may pose challenges for manufacturers of standardized hemostatic products, as healthcare providers seek more customized options for patient care. Understanding and addressing these competitive threats will be crucial for companies looking to maintain their market positions and ensure continued growth.

Another potential restraining factor in the topical absorbable hemostat market is the regulatory and approval challenges associated with the development of new products. The stringent regulations governing the medical device industry can delay the introduction of innovative hemostatic solutions into the market. Furthermore, the increasing focus on safety and efficacy requires manufacturers to invest significantly in research and development to meet regulatory standards. This can result in higher costs and longer timelines for product commercialization, hindering market growth. Companies must navigate these challenges effectively to leverage market opportunities and ensure the successful launch of their hemostatic products.

Competitor Outlook

• Johnson & Johnson
• Medtronic
• Ethicon, Inc.
• Smith & Nephew
• Integra LifeSciences
• Z-Medica
• BD (Becton, Dickinson and Company)
• 3M Company
• Hemostasis, Inc.
• Advanced Medical Solutions Group plc
• TEGA Medical
• Scion Surgical Technologies, LLC
• LeMaitre Vascular, Inc.
• HemCon Medical Technologies
• Bioventus LLC

The competitive landscape of the topical absorbable hemostat market is characterized by the presence of several key players who continuously strive to innovate and enhance their product offerings. Companies like Johnson & Johnson and Medtronic lead the market, leveraging their extensive expertise in medical devices and established distribution networks. Their commitment to research and development enables them to introduce advanced hemostatic solutions that meet the evolving needs of healthcare providers and patients. Furthermore, these companies are actively pursuing strategic partnerships and collaborations to bolster their market presence and expand their product portfolios, ensuring they remain competitive in this dynamic environment.

Ethicon, a subsidiary of Johnson & Johnson, is particularly noteworthy for its comprehensive range of absorbable hemostatic products. The company focuses on developing cutting-edge solutions that improve surgical outcomes and minimize complications. Their investment in innovative technologies allows them to maintain a competitive edge in the market, while their strong brand reputation fosters trust among healthcare providers. Similarly, Medtronic's emphasis on integrating technology into their hemostatic solutions has positioned them as a leading player in the market, showcasing their commitment to enhancing patient care and safety.

Additionally, companies such as Smith & Nephew and Integra LifeSciences are focused on developing specialized hemostatic agents tailored to various surgical applications. Their proactive approach to understanding market trends and addressing customer needs ensures they remain relevant and competitive. Furthermore, with the rise of smaller players like Z-Medica and Hemostasis, Inc., the market is witnessing increased innovation and competition. These companies often offer niche products with unique properties, appealing to specific surgical segments and providing healthcare providers with a broader selection of hemostatic solutions to choose from.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Z-Medica
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 3M Company
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 TEGA Medical
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Bioventus LLC
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Ethicon, Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Smith & Nephew
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Hemostasis, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Johnson & Johnson
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Integra LifeSciences
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 LeMaitre Vascular, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 HemCon Medical Technologies
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Scion Surgical Technologies, LLC
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 BD (Becton, Dickinson and Company)
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Advanced Medical Solutions Group plc
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Topical Absorbable Hemostat Market, By Application
    • 6.1.1 Cardiovascular Surgery
    • 6.1.2 General Surgery
    • 6.1.3 Orthopedic Surgery
    • 6.1.4 Neurosurgery
    • 6.1.5 Others
  • 6.2 Topical Absorbable Hemostat Market, By Product Type
    • 6.2.1 Collagen-based Hemostats
    • 6.2.2 Gelatin-based Hemostats
    • 6.2.3 Oxidized Regenerated Cellulose-based Hemostats
    • 6.2.4 Thrombin-based Hemostats
    • 6.2.5 Combination Hemostats
  • 6.3 Topical Absorbable Hemostat Market, By Ingredient Type
    • 6.3.1 Plant-based
    • 6.3.2 Animal-based
    • 6.3.3 Synthetic
  • 6.4 Topical Absorbable Hemostat Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Ambulatory Surgical Centers
    • 6.4.3 Specialty Clinics
    • 6.4.4 Online Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Topical Absorbable Hemostat Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Topical Absorbable Hemostat market is categorized based on

By Product Type

• Collagen-based Hemostats
• Gelatin-based Hemostats
• Oxidized Regenerated Cellulose-based Hemostats
• Thrombin-based Hemostats
• Combination Hemostats

By Application

• Cardiovascular Surgery
• General Surgery
• Orthopedic Surgery
• Neurosurgery
• Others

By Distribution Channel

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Online Sales

By Ingredient Type

• Plant-based
• Animal-based
• Synthetic

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Johnson & Johnson
• Medtronic
• Ethicon, Inc.
• Smith & Nephew
• Integra LifeSciences
• Z-Medica
• BD (Becton, Dickinson and Company)
• 3M Company
• Hemostasis, Inc.
• Advanced Medical Solutions Group plc
• TEGA Medical
• Scion Surgical Technologies, LLC
• LeMaitre Vascular, Inc.
• HemCon Medical Technologies
• Bioventus LLC